Document Detail


The safety of pharmacological therapies for gastrointestinal conditions encountered during pregnancy.
MedLine Citation:
PMID:  17877438     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Properly assessing the safety of pharmacological therapies for gastrointestinal conditions encountered during pregnancy is a challenge on account of both the often limited controlled data available and the potentially confounding effect of the underlying disorders requiring treatment on fetal outcomes. Here, the available data with regard to gastrointestinal disorders specific to pregnancy, those that may be precipitated or exacerbated by pregnancy and those that may be pre-existing or arise concurrently during pregnancy are reviewed.
Authors:
John A Almeida; Stephen M Riordan
Related Documents :
16634368 - Lupus nephritis and renal disease in pregnancy.
14654658 - The maternal phenylketonuria international study: 1984-2002.
9294858 - Increase in the relative level of type v collagen in the placentae of patients with pre...
18412778 - Thrombophilic mutations in pre-eclampsia and pregnancy-induced hypertension.
22380628 - Multiple pregnancy failures: an immunological paradigm.
18451768 - Developmental origins of childhood overweight: potential public health impact.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Expert opinion on drug safety     Volume:  6     ISSN:  1744-764X     ISO Abbreviation:  Expert Opin Drug Saf     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-09-19     Completed Date:  2007-10-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101163027     Medline TA:  Expert Opin Drug Saf     Country:  England    
Other Details:
Languages:  eng     Pagination:  493-503     Citation Subset:  IM    
Affiliation:
The Prince of Wales Hospital of New South Wales, Gastrointestinal and Liver Unit, Barker Street, Randwick 2031, New South Wales, Sydney, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Female
Gastrointestinal Agents / adverse effects*,  pharmacokinetics
Gastrointestinal Diseases / drug therapy*,  metabolism
Humans
Pregnancy
Pregnancy Complications / drug therapy*,  metabolism
Chemical
Reg. No./Substance:
0/Gastrointestinal Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of safety and quality impact of extractable and leachable substances in therapeutic biolo...
Next Document:  Assessment of safety of the major antimalarial drugs.